Early Signs of Type 2 Diabetes and What Your Gut Has to Do With it

Early Signs of Type 2 Diabetes and What Your Gut Has to Do With it

Type 2 diabetes doesn't appear overnight. For most people, it develops gradually over years, often with subtle warning signs that are easy to dismiss as stress, ageing, or poor sleep. By the time blood sugar levels reach the diagnostic threshold, insulin resistance has usually been present for quite some time.

What many people don't realise is that changes in gut health often precede—and may contribute to—the development of insulin resistance and type 2 diabetes. Emerging research shows that the composition and function of your gut microbiome plays a significant role in how your body regulates blood sugar, processes carbohydrates, and responds to insulin.

This article examines the early warning signs of type 2 diabetes and explores the gut health connections that research is uncovering. Understanding these links doesn't replace medical diagnosis or treatment, but it does offer insight into why supporting gut health may be a valuable component of metabolic wellness.

Important: This article provides educational information only. If you recognise these symptoms, consult your doctor for proper testing and diagnosis. Type 2 diabetes requires medical supervision and management.

What Is Type 2 Diabetes?

Type 2 diabetes is a metabolic condition in which your body becomes resistant to insulin, the hormone that helps glucose (sugar) move from your bloodstream into your cells for energy. Over time, your pancreas can't produce enough insulin to overcome this resistance, leading to chronically elevated blood sugar levels.

Unlike type 1 diabetes (an autoimmune condition), type 2 diabetes develops gradually and is strongly influenced by lifestyle factors including diet, physical activity, body composition, and—as research increasingly shows—gut microbiome health.

Before full diabetes develops, many people go through a stage called prediabetes, where blood sugar levels are elevated but not yet high enough for a diabetes diagnosis. This stage is reversible with lifestyle changes, making early recognition crucial.

Early Warning Signs of Type 2 Diabetes

1. Increased Thirst and Frequent Urination

When blood sugar levels rise, your kidneys work harder to filter and remove the excess glucose. This pulls water from your tissues, leaving you dehydrated and constantly thirsty. The excess glucose is eliminated through urine, leading to more frequent trips to the bathroom—particularly at night.

What to notice: Waking multiple times per night to urinate, drinking significantly more water than usual, or persistent dry mouth even when drinking regularly.

2. Unexplained Fatigue

Insulin resistance prevents glucose from entering your cells efficiently, which means your cells are essentially starving for energy even though your blood is full of sugar. This creates persistent tiredness that doesn't improve with rest.

Additionally, fluctuating blood sugar levels—sharp rises followed by crashes—create energy instability throughout the day.

What to notice: Exhaustion that seems disproportionate to your activity level, afternoon energy crashes, difficulty concentrating, or needing significantly more sleep than before.

3. Increased Hunger (Especially After Eating)

When insulin isn't working properly, your cells don't receive adequate glucose despite eating. This triggers hunger signals even shortly after meals. You may find yourself eating frequently but never feeling truly satisfied.

What to notice: Feeling ravenously hungry 1–2 hours after a full meal, constant snacking, or cravings for carbohydrates and sweets.

4. Blurred Vision

High blood sugar can cause the lens of your eye to swell, changing its shape and affecting your ability to focus. This is usually temporary and improves once blood sugar is controlled, but it's an important early warning sign.

What to notice: Vision that seems to fluctuate—sharper some days, blurrier others—or difficulty reading small print that wasn't previously a problem.

5. Slow-Healing Cuts and Bruises

Elevated blood sugar impairs circulation and damages blood vessels, which slows wound healing. High glucose levels also impair immune function, making infections more likely and harder to clear.

What to notice: Minor cuts taking weeks to heal, bruises that linger, or recurring skin infections (particularly fungal).

6. Tingling or Numbness in Hands and Feet

Chronically high blood sugar damages nerves over time, a condition called diabetic neuropathy. Early signs include tingling, numbness, or a "pins and needles" sensation, typically starting in the feet and hands.

What to notice: Numbness in toes, burning sensations in feet, or reduced sensitivity to temperature in extremities.

7. Darkened Skin Patches (Acanthosis Nigricans)

Insulin resistance can cause dark, velvety patches of skin, usually in body folds—neck, armpits, groin, or knuckles. This condition, called acanthosis nigricans, is a visible marker of insulin resistance and pre-diabetes.

What to notice: Dark, thickened skin in creases that doesn't wash off or lighten with exfoliation.

8. Unexplained Weight Changes

Some people lose weight despite eating normally (because cells aren't absorbing glucose for energy), whilst others gain weight—particularly around the abdomen—due to insulin resistance driving fat storage.

What to notice: Losing weight without trying, or struggling with abdominal weight gain despite no change in diet or exercise.

The Gut-Diabetes Connection: What Research Shows

For decades, type 2 diabetes was understood primarily as a problem of diet, exercise, and genetics. But research over the past 15 years has revealed a crucial additional factor: the gut microbiome.

Gut Bacteria Composition Differs in People with Diabetes

Multiple studies have found that people with type 2 diabetes have distinctly different gut bacteria compared to metabolically healthy individuals. A systematic review examining the gut microbiota in type 2 diabetes patients found that these individuals consistently show moderate dysbiosis, including increases in multiple pathogenic bacteria whilst healthy controls had higher abundance of butyrate-producing bacteria (PubMed: 30366260).

Research examining gut microbiota in European women with type 2 diabetes confirmed distinct bacterial patterns, with diabetic patients showing higher abundance of certain Lactobacillus species that were positively correlated with fasting glucose and glycosylated hemoglobin (HbA1c), whilst specific Clostridium species were negatively correlated with these markers (PMC: PMC8886906).

These changes aren't just a consequence of diabetes—research suggests they may actually contribute to its development. A comprehensive review noted that the gut microbiota is crucially involved in both the initiation and progression of type 2 diabetes (PubMed: 38078135).

Gut Bacteria Influence Blood Sugar Regulation

Your gut microbiome affects glucose metabolism through several mechanisms, as detailed in research examining metabolites linking the gut microbiome with type 2 diabetes risk (PubMed: 32157661):

1. Short-chain fatty acid (SCFA) production
Beneficial bacteria ferment dietary fibre into SCFAs—particularly butyrate, propionate, and acetate. A systematic review and meta-analysis found that increased levels of SCFAs after dietary interventions were associated with lower fasting insulin concentrations and beneficial effects on insulin sensitivity (PMC: PMC10777678). These compounds regulate host glucose homeostasis in part by stimulating secretion of peptide YY (PYY) and glucagon-like peptide-1 (GLP-1) through binding to receptors on intestinal epithelial cells (see our article on GLP-1 and natural satiety support).

2. Intestinal barrier function
A healthy gut lining prevents bacterial fragments and toxins from entering the bloodstream. Research examining the link between leaky gut and diabetes found that alterations in intestinal permeability allow access of infectious agents and dietary antigens to mucosal immune elements, which may lead to immune reactions with damage to pancreatic beta cells and increased cytokine production with consequent insulin resistance (PubMed: 21382153).

When the intestinal barrier becomes compromised, it facilitates the release of bacterial metabolites and endotoxins, such as lipopolysaccharide (LPS), into circulation. This metabolic endotoxemia promotes systemic inflammation that impairs insulin sensitivity (PMC: PMC10954893).

3. Inflammation modulation
Studies examining microbial regulation of glucose metabolism have shown that dysbiosis leads to increased gut permeability, facilitating endotoxemia whereby LPS released by the death of gram-negative bacteria crosses the epithelial barrier and enters circulation, inducing inflammation that impairs insulin sensitivity (PMC: PMC5793163).

Research on gut microbiome, intestinal permeability, and metabolic disease found that patients with type 2 diabetes show reduced microbiome diversity as well as significant reduction in butyrate producers, whilst the number of opportunistic pathogens increased. Reduced gut microbial diversity was associated with insulin resistance, increased circulating inflammation markers, and fatty liver (PMC: PMC7230435).

The Timeline: Gut Changes May Precede Diabetes

A systematic review examining the role of the gut microbiome in diabetes noted that intestinal dysbiosis was consistently observed in the mechanism of gut microbial change in diabetic individuals, contributing to reduced insulin sensitivity and poor glycemic control (PMC: PMC10405753). This suggests that gut microbiome alterations may be an early event in the development of metabolic dysfunction.

This is why supporting gut health may be valuable for metabolic wellness—not as a treatment for diabetes, but as one component of maintaining healthy glucose regulation.

How Gut Health Affects Blood Sugar Control

Fibre Intake and Glucose Regulation

Dietary fibre—particularly soluble and prebiotic types—feeds beneficial gut bacteria that produce SCFAs. A comprehensive systematic review and meta-analysis examined the effects of dietary fibre in adults with prediabetes and type 2 diabetes. Research shows that people with diabetes who ate more fibre (35g daily vs. 19g) had significantly better long-term survival rate (PMC: PMC7059907).

An umbrella review of meta-analyses on dietary fibre and type 2 diabetes found that those consuming the highest amounts of dietary fibre, especially cereal fibre, benefited from a significant reduction in the relative risk of developing type 2 diabetes, with the greatest benefit coming from cereal fibres (PubMed: 29628808).

The mechanism works like this:

  1. You eat prebiotic fibre (chicory root, psyllium, barley, etc.)
  2. Gut bacteria ferment it in your colon
  3. SCFAs are produced (butyrate, propionate, acetate)
  4. SCFAs improve insulin sensitivity and trigger GLP-1 release
  5. Blood sugar regulation improves

This is one reason why diets rich in diverse plant foods consistently show protective effects against type 2 diabetes.

Inflammation and Insulin Resistance

Chronic low-grade inflammation is a major driver of insulin resistance. Research examining intestinal barrier function and immune homeostasis as missing links in obesity and type 2 diabetes development has shown that when gut bacteria are imbalanced, they produce inflammatory compounds that enter circulation and interfere with insulin signalling throughout the body (PMC: PMC8821109).

Supporting a diverse, balanced microbiome through diet helps reduce this inflammatory burden, potentially improving insulin sensitivity.

The Gut-Brain-Pancreas Axis

Your gut bacteria produce neurotransmitters and hormones that communicate with your brain and pancreas. Research on short-chain fatty acids and pancreatic dysfunction found that SCFAs play a pivotal role in regulating insulin and glucagon secretion. GLP-1 produced by intestinal epithelial cells regulates insulin and glucagon secretion directly via GLP-1 receptors on pancreatic cells or via the nervous system (PubMed: 30713129).

A healthy microbiome supports this signalling system; an imbalanced one disrupts it.

What This Means for Prevention and Management

This research doesn't mean:

  • Gut health "cures" diabetes
  • Probiotics or prebiotics replace medication
  • You can ignore diet, exercise, or medical advice

This research does suggest:

  • Gut health is one important factor in metabolic wellness
  • Supporting your microbiome may complement other preventive strategies
  • Dietary diversity and fibre intake matter for blood sugar regulation
  • Early intervention (before diabetes develops) may be particularly valuable

Practical Steps Supported by Research

If you're concerned about diabetes risk or have been told you're prediabetic:

1. Increase dietary fibre gradually
Aim for 25–30g daily from diverse plant sources. The systematic review evidence shows that higher fibre intake is associated with significant reductions in diabetes risk and improved metabolic outcomes (PMC: PMC7059907).

2. Eat 30+ different plant foods per week
Studies show that microbiome diversity is associated with better metabolic health, and dietary diversity is the most effective way to support it.

3. Include prebiotic foods regularly
Chicory root, garlic, onions, leeks, asparagus, oats, and barley all feed beneficial bacteria that support glucose metabolism and SCFA production.

4. Reduce ultra-processed foods
These foods are associated with poorer microbiome health and higher diabetes risk.

5. Move regularly
Physical activity improves both insulin sensitivity and gut microbiome diversity.

6. Manage stress
Chronic stress disrupts both blood sugar regulation and gut health. See our article on stress and gut health for evidence-based strategies.

7. Get adequate sleep
Poor sleep disrupts both glucose metabolism and gut bacteria composition.

Wellsprout's Approach: Supporting Gut Health for Metabolic Wellness

Wellsprout Daily Superblend was designed to support microbiome diversity and metabolic health through whole-food plant ingredients. Our formula includes:

Prebiotic fibres (chicory root, psyllium) that feed bacteria known to produce SCFAs and support insulin sensitivity—the same mechanisms highlighted in the research above.

27 whole-food plants providing the dietary diversity associated with healthier gut bacteria composition and improved metabolic outcomes.

Stress-supporting botanicals (chamomile, tarragon) that help regulate the metabolic impact of chronic stress.

When to See Your Doctor

See your doctor for blood sugar testing if you:

  • Experience several of the early warning signs listed above
  • Have a family history of type 2 diabetes
  • Are overweight or carry weight primarily around your abdomen
  • Have been diagnosed with pre-diabetes in the past
  • Have polycystic ovary syndrome (PCOS)
  • Are over 45 years old (routine screening recommended)
  • Have high blood pressure or cholesterol

Don't wait for symptoms to become severe. Early detection of pre-diabetes allows for intervention before full diabetes develops. The standard tests are:

  • Fasting glucose test: Measures blood sugar after an overnight fast
  • HbA1c test: Shows average blood sugar over 2–3 months
  • Oral glucose tolerance test: Measures how your body processes sugar

Your doctor may also test for insulin resistance, cholesterol, and other metabolic markers.

If diagnosed with pre-diabetes or diabetes: Work with your healthcare team to develop a comprehensive management plan. This typically includes diet, exercise, weight management if needed, and sometimes medication. Gut health support can complement these strategies but never replaces them.

The Bigger Picture: Metabolic Health Is Multifaceted

Type 2 diabetes doesn't develop in isolation. It's part of a broader pattern of metabolic dysfunction that often includes:

  • Insulin resistance
  • Chronic inflammation
  • Oxidative stress
  • Dyslipidaemia (abnormal cholesterol/triglycerides)
  • Hypertension
  • Abdominal obesity

These conditions are interconnected, and gut health appears to influence several of them. This is why a gut-first approach to metabolic wellness—emphasising diverse plant intake, prebiotic support, and inflammatory reduction—shows promise not just for diabetes prevention but for overall metabolic health.

But it's one piece of the puzzle. Genetics, lifestyle, stress, sleep, exercise, and medical care all matter. The most effective approach combines all these elements rather than focusing on any single factor.

The Bottom Line

The early signs of type 2 diabetes such as increased thirst, fatigue, frequent urination, blurred vision, slow wound healing signal that your body's blood sugar regulation is struggling. These symptoms warrant medical evaluation, not self-diagnosis or self-treatment.

Emerging research shows that gut health plays a significant role in glucose metabolism, insulin sensitivity, and inflammation—all key factors in diabetes development. Supporting your microbiome through diverse plant intake and prebiotic fibre may be one valuable component of metabolic wellness.

But gut health support doesn't replace the fundamentals: maintaining a healthy weight, staying physically active, managing stress, getting adequate sleep, and working with healthcare providers for screening and management.

Type 2 diabetes is largely preventable and, in early stages, often reversible through lifestyle changes. The earlier you recognise the signs and take action—with medical guidance—the better your outcomes.

Your gut is part of your metabolic health. So is your doctor.

Related articles:

Looking for ways to add more plants to your meals? Browse our Wellsprout recipes for ideas.

Want to know how your current diet is affecting your gut? Take the free gut health quiz and get your personalised score in 2 minutes.

Medical Disclaimer

This article provides educational information only and is not intended as medical advice. It does not diagnose, treat, cure, or prevent any disease. Type 2 diabetes is a serious medical condition that requires professional diagnosis and management.

If you recognise symptoms of diabetes, consult your doctor for proper testing. If you have been diagnosed with pre-diabetes or diabetes, work with your healthcare team to develop an appropriate treatment plan. Do not make changes to diabetes medications or treatment protocols without medical supervision.

Wellsprout Daily Superblend is a food supplement, not a diabetes medication or treatment. It does not replace medical care, blood sugar monitoring, or prescribed medications. Any dietary changes, including adding supplements, should be discussed with your healthcare provider, particularly if you have diabetes, pre-diabetes, or take medications that affect blood sugar.

The research discussed in this article examines connections between gut health and metabolic function.

References

Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008). Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet–induced obesity and diabetes in mice. Diabetes, 57(6), 1470–1481. https://pubmed.ncbi.nlm.nih.gov/18305141/

Cani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D. M., Muccioli, G. G., & Delzenne, N. M. (2009). Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut, 58(8), 1091–1103. https://pubmed.ncbi.nlm.nih.gov/19240062/

De Kort, S., Keszthelyi, D., & Masclee, A. A. (2011). Leaky gut and diabetes mellitus: what is the link? Obesity Reviews, 12(6), 449–458. https://pubmed.ncbi.nlm.nih.gov/21382153/

den Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D. J., & Bakker, B. M. (2013). The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. Journal of Lipid Research, 54(9), 2325–2340. https://pubmed.ncbi.nlm.nih.gov/23821742/

Ley, S. H., Hamdy, O., Mohan, V., & Hu, F. B. (2014). Prevention and management of type 2 diabetes: dietary components and nutritional strategies. The Lancet, 383(9933), 1999–2007. https://pubmed.ncbi.nlm.nih.gov/24910231/

Marshall, M. M., & McCullough, R. (2018). Dietary Fiber Intake and Type 2 Diabetes Mellitus: An Umbrella Review of Meta-analyses. Journal of the American College of Nutrition, 37(4), 293–306. https://pubmed.ncbi.nlm.nih.gov/29628808/

Muñoz-Garach, A., Diaz-Perdigones, C., & Tinahones, F. J. (2016). Gut microbiota and type 2 diabetes mellitus. Endocrinología, Diabetes y Nutrición, 63(10), 560–568. https://pubmed.ncbi.nlm.nih.gov/27717489/

Nirmalkar, K., Murugesan, S., Pizano-Zárate, M. L., Villalobos-Flores, L. E., García-González, C., Morales-Hernández, R. M., Nuñez-Hernández, J. A., Hernández-Quiroz, F., Romero-Figueroa, M. D. S., Hernández-Land, M. G., & Hoyo-Vadillo, C. (2018). Gut microbiota and endothelial dysfunction markers in obese Mexican children and adolescents. Nutrients, 10(12), 2009. https://pubmed.ncbi.nlm.nih.gov/30562958/

Reynolds, A. N., Akerman, A. P., & Mann, J. (2020). Dietary fibre and whole grains in diabetes management: Systematic review and meta-analyses. PLOS Medicine, 17(3), e1003053. https://pubmed.ncbi.nlm.nih.gov/32142510/

Sadagopan, A., Mahmoud, A., Begg, M., Tarhuni, M., Fotso, M., Gonzalez, N. A., Sanivarapu, R. R., Osman, U., Kumar, A. L., & Mohammed, L. (2023). Understanding the Role of the Gut Microbiome in Diabetes and Therapeutics Targeting Leaky Gut: A Systematic Review. Cureus, 15(7), e41559. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405753/

Sharma, S., & Tripathi, P. (2019). Gut microbiome and type 2 diabetes: where we are and where to go? The Journal of Nutritional Biochemistry, 63, 101–108. https://pubmed.ncbi.nlm.nih.gov/30366260/

Sircana, A., Framarin, L., Leone, N., Berrutti, M., Castellino, F., Parente, R., De Michieli, F., Paschetta, E., & Musso, G. (2018). Altered gut microbiota in type 2 diabetes: Just a coincidence? Current Diabetes Reports, 18(10), 98. https://pubmed.ncbi.nlm.nih.gov/30171447/

Thingholm, L. B., Rühlemann, M. C., Koch, M., Fuqua, B., Laucke, G., Boehm, R., Bang, C., Franzosa, E. A., Hübenthal, M., Rahnavard, A., Frost, F., Lloyd-Price, J., Schirmer, M., Lusis, A. J., Vulpe, C. D., Lerch, M. M., Homuth, G., Kacprowski, T., Schmidt, C. O., ... Franke, A. (2019). Obese individuals with and without type 2 diabetes show different gut microbial functional capacity and composition. Cell Host & Microbe, 26(2), 252–264. https://pubmed.ncbi.nlm.nih.gov/31327826/

Tilg, H., & Moschen, A. R. (2014). Microbiota and diabetes: an evolving relationship. Gut, 63(9), 1513–1521. https://pubmed.ncbi.nlm.nih.gov/24833634/

Zhao, L., Zhang, F., Ding, X., Wu, G., Lam, Y. Y., Wang, X., Fu, H., Xue, X., Lu, C., Ma, J., Yu, L., Xu, C., Ren, Z., Xu, Y., Xu, S., Shen, H., Zhu, X., Shi, Y., Shen, Q., ... Zhang, C. (2018). Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science, 359(6380), 1151–1156. https://pubmed.ncbi.nlm.nih.gov/29590046/

Zhou, W., Chow, K. M., Fleming, E., & Oh, J. J. (2019). Gut microbiota: An important player in type 2 diabetes mellitus. Frontiers in Cellular and Infection Microbiology, 12, 834485. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886906/

Ziętak, M., Kovatcheva-Datchary, P., Markiewicz, L. H., Ståhlman, M., Kozak, L. P., & Bäckhed, F. (2016). Altered microbiota contributes to reduced diet-induced obesity upon cold exposure. Cell Metabolism, 23(6), 1216–1223. https://pubmed.ncbi.nlm.nih.gov/27304513/

de Wouters d'Oplinter, A., Rastelli, M., Van Hul, M., Delzenne, N. M., Cani, P. D., & Everard, A. (2020). Gut microbiome, intestinal permeability, and tissue bacteria in metabolic disease: Perpetrators or bystanders? Microorganisms, 8(4), 608. https://pubmed.ncbi.nlm.nih.gov/32295104/

Gurung, M., Li, Z., You, H., Rodrigues, R., Jump, D. B., Morgun, A., & Shulzhenko, N. (2020). Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine, 51, 102590. https://pubmed.ncbi.nlm.nih.gov/31901868/

Gao, X., Zhang, M., Xue, J., Huang, J., Zhuang, R., Zhou, X., Zhang, H., Fu, Q., & Hao, Y. (2018). Body mass index differences in the gut microbiota are gender specific. Frontiers in Microbiology, 9, 1250. https://pubmed.ncbi.nlm.nih.gov/29942308/

Boulangé, C. L., Neves, A. L., Chilloux, J., Nicholson, J. K., & Dumas, M. E. (2016). Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Medicine, 8(1), 42. https://pubmed.ncbi.nlm.nih.gov/27098727/

Scheithauer, T. P. M., Rampanelli, E., Nieuwdorp, M., Vallance, B. A., Verchere, C. B., van Raalte, D. H., & Herrema, H. (2020). Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes. Frontiers in Immunology, 11, 571731. https://pubmed.ncbi.nlm.nih.gov/33117373/

Huang, Y., Wang, Z., Ma, H., Ji, S., Chen, Z., Cui, Z., Chen, J., & Tang, S. (2023). Short-chain fatty acids and insulin sensitivity: a systematic review and meta-analysis. Nutrition Reviews, 82(2), 193–209. https://pubmed.ncbi.nlm.nih.gov/37290429/

Canfora, E. E., Jocken, J. W., & Blaak, E. E. (2015). Short-chain fatty acids in control of body weight and insulin sensitivity. Nature Reviews Endocrinology, 11(10), 577–591. https://pubmed.ncbi.nlm.nih.gov/26260141/

Anil Kumar, S., & Hima Kumari, P. (2019). Short Chain Fatty Acids, pancreatic dysfunction and type 2 diabetes. Pancreatology, 19(2), S30. https://pubmed.ncbi.nlm.nih.gov/30713129/

Back to blog